Candel Therapeutics Inc (CADL)

SG&A Expenses

$6.95M

Quarterly · Period ending: · USD

CADL logo

CADL SG&A Expenses

Latest reported$6.95M
CADL Quarterly SG&A Expenses ($728.00K → $6.95M)
High-resolution chart · PNG

CADL sg&a expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Candel Therapeutics Inc SG&A Expenses — Quarterly (USD)
Period endingSG&A Expenses (USD)
6,945,000
6,444,000
4,724,000
4,746,000
4,186,000
4,114,000
3,324,000
3,341,000
3,592,000
3,800,000
3,060,000
3,016,000
3,645,000
4,164,000
3,160,000
3,536,000
3,762,000
3,600,000
3,917,000
2,795,000
2,040,000
1,935,000
3,434,000
967,000
855,000
728,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.